Navigation Links
I-SPY 2 study speeds up treatment for breast cancer
Date:11/19/2010

AURORA, Colo. (Nov. 16, 2010) A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital. This study, called I-SPY 2, (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2) will evaluate which medical treatments are most effective for different types of tumors. So-called "personalized medicine" in cancer is gaining ground as new drugs are developed that target known gene mutations. In the past, "it could take hundreds of thousands of dollars and several years to study a single drug", says Anthony Elias, MD, breast cancer program director and associate director for clinical research at the University of Colorado Cancer Center (UCCC). "This trial sets up a new kind of mechanism that lets us test multiple drugs at nearly two dozen cancer centers at once, starting with three drugs that have been shown to target known gene abnormalities in common subtypes of breast cancer," Elias says. "Rapid discovery is the name of the game."

UCCC is participating with 20 leading cancer centers in the United States and Canada recruiting and treating patients as part of this large-scale clinical trial aimed at quickly developing new breast cancer drugs. Women who participate will have a new diagnosis of breast cancer and can not have received any previous treatment including surgery. Their breast tumor biopsy is tested using three high-tech biological screening tools. The results will tell doctors what gene mutations are driving their cancer. If the gene testing results show a tumor it may be less likely to respond to currently available chemotherapy agents, the patient will be invited to enter the drug trial.

"HER2 and triple negative breast cancers are usually bad actors, but some of the ER positive breast cancers can also be aggressive," Elias says. "E
'/>"/>

Contact: Jackie Brinkman
jackie.brinkman@ucdenver.edu
303-724-1525
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Outreach, Enforcement Can Curb College Kids Drinking: Study
2. UH physicists study behavior of enzyme linked to Alzheimers, cancer
3. British Study Supports Mammograms for Some Women Under 50
4. Spleen Cells Tied to Damage of Spinal Cord Injury in Animal Study
5. Undergrads Who Twitter May Do Better, Study Finds
6. HIV Patients Do Well After Kidney Transplants: Study
7. Lung cancer patients are the centerpiece for Northwestern medicine quality of care study
8. Study Reports More Precise Way to Remove Cataracts
9. Long-Term Statin Use Wont Up Cancer Risk: Study
10. Toronto Western Hospital study demonstrates improved wait times for patients suffering back pain
11. Higher Plavix Dose Wont Boost Outcomes After Stent Placement: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 04, 2015 Leonardo J. Lozada, ... chief physician executive, and William C. Daniel, M.D., Saint ... accepted personal invitations from the Secretary of the Air ... (NSF) at the Air War College, Maxwell Air Force ... influential citizens to senior U.S. and international officers and ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Each year, the ... to raise funds and awareness for breast cancer. This year, ... will be featured as the entertainment sponsor for the 25th ... on May 9 at the Lenox Square Mall. , The ... race, and to raise $1.2 million. Perimeter Plastic Surgery has ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be ... Group (RUG) Conference in Baltimore, MD from May 11 ... Group provides an opportunity for clients to gather to ... , In addition to sponsoring the event, TROY Healthcare ... RUG Conference. Attendees can stop by the TROY booth ...
(Date:5/4/2015)... May 04, 2015 In May of 2010, ... his own life. In the wake of this tragedy, Ty’s ... an organization that exposes the grim reality of bullying and ... platform for Kirk and Laura to share their story and ... from happening to another family — a mission that took ...
(Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2
... ten kids think that low-fat crisp, ketchup and bread are a ... ,The study also revealed that one-third of the children between ... in the list and almost 15 pct call pasta vegetable. ... ,"It is clear from our findings that children still need to ...
... vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease ... , San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical ... is the leading viral cause of birth defects and a ... natural immunity doesnt protect against infection by the virus, estimated ...
... central government funds allocated to fight chikungunya last year ... were struggling against the mosquito-borne disease that had ... ,According to data available with the health ministry, ... the worst-affected 16 states to help them contain the ...
... bio-refinery in the Gulf region, which will produce ethanol mainly ... a substitute for petrol and diesel, local newspaper Khaleej Times ... US$28.65 million to build a bio-refinery imported from Brazil in ... according to the report. ,The plant, expected to ...
... was addicted to crystal methamphetamine addiction eight years ago, that she ... Peas' singer revealed that she talked to the basket thinking someone ... ,"I remember thinking somebody was inside of it, going to ... who was crawling in the hamper, the New York Post quoted ...
... The NHS must provide more flexible working, the BMA says today ... embarking on NHS careers outnumber men by almost three to two. ... UK medical schools in 2006 will be surveyed by the BMA ... female, compared with 51% in 1995, when the BMA launched a ...
Cached Medicine News:Health News:New Vaccine for CMV Infection 2Health News:New Vaccine for CMV Infection 3Health News:Chikungunya Spreads as Funds Remain Unspent 2Health News:BMA Calls for Flexible Working as Number of Women Doctors Swell 2
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has ... (Bayer) to develop and commercialize ISIS-FXI Rx for ... agreement, Isis is eligible to receive up to $155 ... up-front payment and a $55 million payment upon advancement ... patients with compromised kidney function. Isis is also eligible ...
(Date:5/4/2015)... , May 4, 2015  FireflySci Inc., the newest member of the cuvette manufacturing ... they have turned the cuvette industry on its head by offering scientists amazing support for their ... Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3
... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... with operations in China and the United States, today ... second quarter of 2011 after the New York Stock ... be Thursday morning, August 11, 2011 Shanghai time). The ...
... RAPIDS, Mich., July 19, 2011 ... rehabilitation and software services that benefit patients, healthcare ... to its multi-state group of outpatient clinics.  Agility ... the Company,s Michigan-based outpatient clinic presence to 23 ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2Agility Health Expands National Outpatient Clinic Group with New Michigan Facility 2
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Inquire...
Medicine Products: